Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05304962 |
Title | FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Regor Pharmaceuticals Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Hem-Onc Associates of the Treasure Coast | ACTIVE_NOT_RECRUITING | Port Saint Lucie | Florida | 34952 | United States | Details |
Emory University | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
Massachusetts General Hospital | RECRUITING | Boston | Massachusetts | 02142 | United States | Details |
Washington University School of Medicine | RECRUITING | Saint Louis | Missouri | 63110 | United States | Details |
New York Cancer and Blood Specialists | RECRUITING | Port Jefferson Station | New York | 11776 | United States | Details |